Robeco Institutional Asset Management B.V. Acquires 121,979 Shares of The Clorox Company (NYSE:CLX)

Robeco Institutional Asset Management B.V. raised its position in The Clorox Company (NYSE:CLX - Free Report) by 49.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 370,880 shares of the company's stock after buying an additional 121,979 shares during the quarter. Robeco Institutional Asset Management B.V. owned 0.30% of Clorox worth $60,235,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the company. Brooklyn Investment Group grew its position in shares of Clorox by 163.8% during the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company's stock worth $25,000 after purchasing an additional 95 shares in the last quarter. Prospera Private Wealth LLC acquired a new stake in Clorox during the third quarter worth approximately $27,000. Continuum Advisory LLC increased its stake in Clorox by 300.0% during the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company's stock worth $30,000 after acquiring an additional 138 shares during the period. Quarry LP raised its holdings in Clorox by 99.1% in the 2nd quarter. Quarry LP now owns 229 shares of the company's stock valued at $31,000 after acquiring an additional 114 shares in the last quarter. Finally, Carolina Wealth Advisors LLC bought a new stake in shares of Clorox during the 3rd quarter valued at $48,000. Institutional investors own 78.53% of the company's stock.

Analysts Set New Price Targets

CLX has been the topic of a number of analyst reports. StockNews.com downgraded shares of Clorox from a "buy" rating to a "hold" rating in a research note on Sunday, January 5th. DA Davidson boosted their price objective on shares of Clorox from $153.00 to $171.00 and gave the company a "neutral" rating in a research report on Monday, November 4th. Barclays decreased their price target on Clorox from $139.00 to $130.00 and set an "underweight" rating on the stock in a research note on Friday, January 17th. Wells Fargo & Company upgraded Clorox from an "underweight" rating to an "equal weight" rating and upped their price objective for the stock from $155.00 to $157.00 in a research report on Tuesday, January 7th. Finally, JPMorgan Chase & Co. lifted their target price on Clorox from $167.00 to $171.00 and gave the company a "neutral" rating in a research report on Thursday, January 16th. Four analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the company's stock. Based on data from MarketBeat, Clorox presently has an average rating of "Hold" and a consensus price target of $156.54.

Clorox Trading Up 1.1 %

Shares of CLX traded up $1.68 during mid-day trading on Thursday, reaching $159.49. 115,260 shares of the company were exchanged, compared to its average volume of 974,220. The business has a 50 day simple moving average of $163.15 and a two-hundred day simple moving average of $158.01. The Clorox Company has a 52 week low of $127.60 and a 52 week high of $171.37. The stock has a market capitalization of $19.74 billion, a PE ratio of 55.56, a PEG ratio of 2.92 and a beta of 0.42. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, beating analysts' consensus estimates of $1.36 by $0.50. The company had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The company's quarterly revenue was up 27.0% on a year-over-year basis. During the same period in the prior year, the firm posted $0.49 EPS. On average, analysts predict that The Clorox Company will post 6.87 earnings per share for the current fiscal year.

Clorox Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be paid a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.06%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox's dividend payout ratio is 170.04%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.